UBS Group
KTOVW

UBS Group’s Kitov Pharma Ltd. Warrants KTOVW Stock Holding History

UBS Group’s Portfolio KTOVW Stock Details KTOVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,845
Closed – – 8697
2019
Q4 		$0 Sell
3,845
-40
-1% -$3 ﹤0.01% 8617
2019
Q3 		$0 Buy
3,885
+501
+15% +$61 ﹤0.01% 8446
2019
Q2 		$0 Buy
3,384
+700
+26% +$111 ﹤0.01% 8350
2019
Q1 		$1K Buy
2,684
+1,803
+205% +$404 ﹤0.01% 7611
2018
Q4 		$0 Buy
881
+185
+27% +$71 ﹤0.01% 8475
2018
Q3 		$0 Buy
+696
New +$400 ﹤0.01% 8422
2018
Q2 		– Sell
-1,940
Closed -$1K – 8394
2018
Q1 		$1K Sell
1,940
-3,300
-63% -$2.37K ﹤0.01% 7700
2017
Q4 		$3K Buy
5,240
+2,640
+102% +$1.82K ﹤0.01% 7565
2017
Q3 		$2K Buy
+2,600
New +$1.45K ﹤0.01% 7513
2016
Q2 		– Sell
-4,940
Closed -$5K – 8092
2016
Q1 		$5K Buy
+4,940
New +$3.11K ﹤0.01% 7027

Other funds holding KTOVW

CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

UBS Group's KTOVW Position: Q1 2020 in Review

UBS Group sold out of Kitov Pharma Ltd. Warrants (KTOVW) in Q1 2020, closing a stake of 3,845 shares.

UBS Group first reported a position in KTOVW in Q1 2016 and held it in 10 quarters. The position peaked at $5K in Q1 2016. 1 fund tracked by Wall St. Rank holds KTOVW as of Q1 2020.

  • UBS Group reported no remaining Kitov Pharma Ltd. Warrants position as of Q1 2020 after selling out during the quarter.
  • UBS Group sold 3,845 Kitov Pharma Ltd. Warrants shares in Q1 2020.
  • UBS Group first reported a position in Kitov Pharma Ltd. Warrants in Q1 2016 and held it in 10 quarters.
  • UBS Group's Kitov Pharma Ltd. Warrants position peaked at $5K in Q1 2016.
  • 1 fund tracked by Wall St. Rank held Kitov Pharma Ltd. Warrants as of Q1 2020.

Based on UBS Group's 13F filing for Q1 2020, filed 1 May 2020.